<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2026.94.25</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-3346</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEWS</subject></subj-group></article-categories><title-group><article-title>Предикторы длительного персистирования фетальных коммуникаций: клиническое значение и прогноз</article-title><trans-title-group xml:lang="en"><trans-title>Predictors of prolonged persistence of fetal communications: clinical significance and prognosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8507-6968</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саввина</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Savvina</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Саввина Майя Семеновна ‒ канд. мед. наук, ст. науч. сотр. ЯНЦ КМП.</p><p>677000, Якутск, ул. Ярославского 6/3</p></bio><email xlink:type="simple">maya_savvina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нелунова</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Nelunova</surname><given-names>T. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нелунова Туяра Ивановна – канд. мед. наук, врач – кардиолог Перинатального центра Якутской РКБ.</p><p>ул. Стадухина, 81/9, Якутск, 677005</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5490-2072</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурцева</surname><given-names>Т. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Burtseva</surname><given-names>T. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бурцева Татьяна Егоровна – д-р мед. наук, проф., проф. кафедры «Педиатрия и детская хирургия» ФГАОУ ВО «СВФУ им. М.К. Аммосова»; вед. науч. сотр. – руковод. лабораторией мониторинга состояния здоровья детей и медико-экологических исследований ФГБНУ «ЯНЦ КМП».</p><p>ул. Кирова, д. 7, Якутск, 677018; ул. Кулаковского, 36, Якутск, 677000</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГБНУ «Якутский научный центр комплексных медицинский проблем»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Перинатальный центр Якутской республиканской клинической больницы</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>ФГБНУ «Якутский научный центр комплексных медицинский проблем»; ФГАОУ ВО «Северо-Восточный федеральный университет им. М.К. Аммосова»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>21</day><month>06</month><year>2026</year></pub-date><volume>0</volume><issue>2</issue><fpage>114</fpage><lpage>118</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Саввина М.С., Нелунова Т.И., Бурцева Т.Е., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Саввина М.С., Нелунова Т.И., Бурцева Т.Е.</copyright-holder><copyright-holder xml:lang="en">Savvina M.S., Nelunova T.I., Burtseva T.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/3346">https://ymj.elpub.ru/jour/article/view/3346</self-uri><abstract><p>Известно, что фетальные коммуникации ‒ это патологические состояния, при котором сохраняются элементы внутриутробного кровообращения после рождения, приводящие к нарушению оксигенации и гипоксемии новорожденных. В обзоре проведен анализ источников литературы, рассмотрены причины возникновения, патогенез, факторы риска и коррекция фетальных коммуникаций (функционирующий артериальный проток, открытое овальное окно). Данная патология является серьезной проблемой, требующей немедленного вмешательства при ее гемодинамической значимости. Исход лечения зависит от ранней диагностики и выбора правильной тактики ведения.</p></abstract><trans-abstract xml:lang="en"><p>It is known that fetal communications are pathological conditions in which elements of intrauterine blood circulation remain after birth, leading to impaired oxygenation and hypoxemia of newborns. The review analyzes the literature sources, examines the causes, pathogenesis, risk factors and correction of fetal communications (functioning ductus arteriosus, open oval window). This pathology is a serious problem requiring immediate intervention in case of its hemodynamic significance. The outcome of treatment depends on early diagnosis and choosing the right management tactics.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фетальные коммуникации</kwd><kwd>функционирующий артериальный проток</kwd><kwd>открытое овальное окно</kwd><kwd>новорожденные</kwd><kwd>недоношенные дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fetal communications</kwd><kwd>functioning ductus arteriosus</kwd><kwd>patent foramen ovale</kwd><kwd>newborn</kwd><kwd>premature babies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Remien K., Majmundar S.H. Physiology, Fetal Circulation Treasure Island (FL): StstPearls Publishing, 2025. PMID: 30969532</mixed-citation><mixed-citation xml:lang="en">Remien K., Majmundar S.H. Physiology, Fetal Circulation Treasure Island (FL): StstPearls Publishing, 2025. PMID: 30969532</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Calvert P.A., Rana B.S., Kydd A.C. et al. Patent foramen ovale: anatomy, outcomes and closure. Nature Reviews Cardiology. 2011. №3 (8): 148-160. Doi: 10.1038/nrcardio.2010.224</mixed-citation><mixed-citation xml:lang="en">Calvert P.A., Rana B.S., Kydd A.C. et al. Patent foramen ovale: anatomy, outcomes and closure. Nature Reviews Cardiology. 2011. №3 (8): 148-160. Doi: 10.1038/nrcardio.2010.224</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shah S.N., Horlic F.M., Kass M. et al. The pathophysiology of patent foramen ovale and its related complications. Am. Heart J. 2024. 277:76-92. Doi: 10.1016/j.ahj.2024.08.001</mixed-citation><mixed-citation xml:lang="en">Shah S.N., Horlic F.M., Kass M. et al. The pathophysiology of patent foramen ovale and its related complications. Am. Heart J. 2024. 277:76-92. Doi: 10.1016/j.ahj.2024.08.001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hampton T., Alsaleem M., Murphy-Lavoie H.M. Patent Foramen Ovale Treasure Island (FL): StatPearls Publishing. 2025. PMID: 29630203</mixed-citation><mixed-citation xml:lang="en">Hampton T., Alsaleem M., Murphy-Lavoie H.M. Patent Foramen Ovale Treasure Island (FL): StatPearls Publishing. 2025. PMID: 29630203</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S., Seo Y., Oh M.Y. et al. Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia. Biomedicines. 2025. 13(7): 1725. Doi: 10.3390/biomedicines13071725</mixed-citation><mixed-citation xml:lang="en">Kim S., Seo Y., Oh M.Y. et al. Impact of Pulmonary Hypertension and Patent Ductus Arteriosus in Preterm Infants with Presumed Pulmonary Hypoplasia. Biomedicines. 2025. 13(7): 1725. Doi: 10.3390/biomedicines13071725</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Артюх Л.Ю., Карелина Н.Н., Красногорская О.К. Современный взгляд на классификацию и диагностику открытого артериального протока (обзор). Российские биомедицинские исследования. 2023; 2 (8): 78-91. Doi: 1056871/RBR.2023.95.14010</mixed-citation><mixed-citation xml:lang="en">Artyukh L.Yu., Karelina N.R., Oppedisano MGL et al. A modern view on the classification and diagnosis of the open arterial duct (review). Russian biomedical research (St. Petersburg). 2023. 8(2): 78-91 (In Russian). Doi: 1056871/RBR.2023.95.14010</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Abu-Shaweesh J.M., Almidani E. PDA: Does it matter? International Journal of Pediatrics and Adolescent Medicine. 2020. 1(7):11. Doi: 10.1016/j.ijpam.2019.12.001</mixed-citation><mixed-citation xml:lang="en">Abu-Shaweesh J.M., Almidani E. PDA: Does it matter? International Journal of Pediatrics and Adolescent Medicine. 2020. 1(7):11. Doi: 10.1016/j.ijpam.2019.12.001</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cucerea M., Marian R., Simon M. et al. Serum Biomarkers in Patent Ductus Arteriosus in Preterm Infants: A Narrative Review. Biomedicines. 2025. 3(13): 670</mixed-citation><mixed-citation xml:lang="en">Cucerea M., Marian R., Simon M. et al. Serum Biomarkers in Patent Ductus Arteriosus in Preterm Infants: A Narrative Review. Biomedicines. 2025. 3(13): 670</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ovali F. Molecular and Mechanical Mechanisms regulating Ductus Arteriosus Closure in Preterm Infants. Frontiers in Pediatrics. 2020. 8:516. Doi: 10.3389/fped.2020.00516</mixed-citation><mixed-citation xml:lang="en">Ovali F. Molecular and Mechanical Mechanisms regulating Ductus Arteriosus Closure in Preterm Infants. Frontiers in Pediatrics. 2020. 8:516. Doi: 10.3389/fped.2020.00516</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sk M.H., Singh P., Saha B. Hemodynamically significant patent ductus arteriosus profile in preterm neonates (26-34 weeks gestation) undergoing surfactant replacement therapy in India: a prospective observational study. Journal of Tropical Pediatrics. 2024. 70 (5): fmae 021. Doi: 10.1093(tropej)fmae021.</mixed-citation><mixed-citation xml:lang="en">Sk M.H., Singh P., Saha B. Hemodynamically significant patent ductus arteriosus profile in preterm neonates (26-34 weeks gestation) undergoing surfactant replacement therapy in India: a prospective observational study. Journal of Tropical Pediatrics. 2024. 70 (5): fmae 021. Doi: 10.1093(tropej)fmae021.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cucerea M., Moscalu M., Ognean M.-L. et al. Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24h in Preterm Neonates Less than 32 Weeks of Gestational Age. Biomedicines. 2024; 6(12): 1136. Doi: 10.3390/biomedicines12061136</mixed-citation><mixed-citation xml:lang="en">Cucerea M., Moscalu M., Ognean M.-L. et al. Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24h in Preterm Neonates Less than 32 Weeks of Gestational Age. Biomedicines. 2024; 6(12): 1136. Doi: 10.3390/biomedicines12061136</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ognean M.L., Boanta O., Kovacs S. et al. Persistent Ductus Arteriosus in Critically I11 Preterm Infants. The Journal of Critical Care Medicine. 2016. 4 (2): 175-184. Doi: 10.1515/jccm-2016-0026</mixed-citation><mixed-citation xml:lang="en">Ognean M.L., Boanta O., Kovacs S. et al. Persistent Ductus Arteriosus in Critically I11 Preterm Infants. The Journal of Critical Care Medicine. 2016. 4 (2): 175-184. Doi: 10.1515/jccm-2016-0026</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Babla K., Dassios T., Pushparajah K et al. Premature infants with patent ductus arteriosus: Postnatal growth according to type of management. Pediatrics &amp; Neonatology. 2021. 1 (62): 36-40. Doi: 10.1016/j-pedneo.2020.08.005</mixed-citation><mixed-citation xml:lang="en">Babla K., Dassios T., Pushparajah K et al. Premature infants with patent ductus arteriosus: Postnatal growth according to type of management. Pediatrics &amp; Neonatology. 2021. 1 (62): 36-40. Doi: 10.1016/j-pedneo.2020.08.005</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nagafuji M., Fujiyama S., Doki K. et al. Assessment of Blood Prostaglandin E2 Metabolite Levels among Infants Born Preterm with Patent Ductus Arteriosus: A Prospective Study. The Journal of Pediatrics. 2025. 276: 114285. Doi: 10.1016/j.jpeds.2024.114285</mixed-citation><mixed-citation xml:lang="en">Nagafuji M., Fujiyama S., Doki K. et al. Assessment of Blood Prostaglandin E2 Metabolite Levels among Infants Born Preterm with Patent Ductus Arteriosus: A Prospective Study. The Journal of Pediatrics. 2025. 276: 114285. Doi: 10.1016/j.jpeds.2024.114285</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Спивак Е.М. Способы прогнозирования персистенции артериального протока у глубоконедоношенных новорожденных (обзор литературы). Неонатология: Новости. Мнения. Обучение. 2022; 1(35) (10): 29-33 Doi: 10.33029/2308-2402-2022-10-1-29-33.</mixed-citation><mixed-citation xml:lang="en">Spivac E.M. Methods for predicting ductus arteriosus persistence in preterm infants (literature review). Neonatologiya: novosti, mneniya, obuchenie [Neonatology: news, opinions, training]. 2022. 10(1): 29-33. Doi: https: //doi.org/10.33029/2308-2402-2022-10-1-29-33 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C., Zhu X, Li D. et al. Related Factors of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics. 2021. 5 (8): 605879. Doi: 10.3389/fped.2020.605879</mixed-citation><mixed-citation xml:lang="en">Liu C., Zhu X, Li D. et al. Related Factors of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis. Frontiers in Pediatrics. 2021. 5 (8): 605879. Doi: 10.3389/fped.2020.605879</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Giesinger R.E., Hobson A.A., Bischoff A.R. et al. Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in “22-23” week and “24-26” infants Elsevier. 2023. 47(2):151721. Doi: 10.1016/j.semperi.2023.151721</mixed-citation><mixed-citation xml:lang="en">Giesinger R.E., Hobson A.A., Bischoff A.R. et al. Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in “22-23” week and “24-26” infants Elsevier. 2023. 47(2):151721. Doi: 10.1016/j.semperi.2023.151721</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Климачева О.В., Климачев А.М., Спивак Е.М. Патент РФ №2556793С1. Способ постнатального прогнозирования персистенции гемодинамически значимого открытого артериального протока у недоношенных детей</mixed-citation><mixed-citation xml:lang="en">Climacheva O.V., Climachev A.M., Spivac E.M. Patent №2556793C1. Method for postnatal prediction of persistence of hemodynamically significant open ductus in preterm infants (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">El-Khuffash A., Bussmann N., Breatnach C.R. et al. A pilot Randomized Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score (The PDA RCT). The Journal of Pediatrics. 2021. (229):127-133. Doi: 10.1016/j.jpeds.2020.10.024</mixed-citation><mixed-citation xml:lang="en">El-Khuffash A., Bussmann N., Breatnach C.R. et al. A pilot Randomized Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score (The PDA RCT). The Journal of Pediatrics. 2021. (229):127-133. Doi: 10.1016/j.jpeds.2020.10.024</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Smith A., Mullary R., Franklin O. et al. Reproducibility of the EL-Khuffash PDA severity score and PDA diameter measurements in extremely preterm infants. Early Human Development. 2023. (184): 105832. Doi: 10.1016/j.earl-humdev.2023.105832</mixed-citation><mixed-citation xml:lang="en">Smith A., Mullary R., Franklin O. et al. Reproducibility of the EL-Khuffash PDA severity score and PDA diameter measurements in extremely preterm infants. Early Human Development. 2023. (184): 105832. Doi: 10.1016/j.earl-humdev.2023.105832</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rolland A., Shankar-Aguilera S., Diomande D. et al. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Archives of Disease in Childhood – Fetal and Neonatal Edition. 2015.1(100): F55-58. Doi: 10.1136/arch-dischild-2014-306339</mixed-citation><mixed-citation xml:lang="en">Rolland A., Shankar-Aguilera S., Diomande D. et al. Natural evolution of patent ductus arteriosus in the extremely preterm infant. Archives of Disease in Childhood – Fetal and Neonatal Edition. 2015.1(100): F55-58. Doi: 10.1136/arch-dischild-2014-306339</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Rios D.R., Martins F. de F., El-Khuffash A. et al. Early Role of the Atrial-Level Communication in Premature Infants with Patent Ductus Arteriosus. Journal of the American Society of Echocardiography. 2021.4(34): 423-432. Doi: 10.1016/j.echo.2020.11.008</mixed-citation><mixed-citation xml:lang="en">Rios D.R., Martins F. de F., El-Khuffash A. et al. Early Role of the Atrial-Level Communication in Premature Infants with Patent Ductus Arteriosus. Journal of the American Society of Echocardiography. 2021.4(34): 423-432. Doi: 10.1016/j.echo.2020.11.008</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gaffar S., Siassi B., Cayabyab R. et al. Outcomes of patent foramen ovale greater than 3mm at birth in extremely low birthweight infants. BMC Pediatrics. 2023. 1(23): 293. Doi: 10.1186/s12887-023-04119-6</mixed-citation><mixed-citation xml:lang="en">Gaffar S., Siassi B., Cayabyab R. et al. Outcomes of patent foramen ovale greater than 3mm at birth in extremely low birthweight infants. BMC Pediatrics. 2023. 1(23): 293. Doi: 10.1186/s12887-023-04119-6</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mas J.-L., Derumeaux G., Guillon B. et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. New England Journal of Medicine. 2017. 11(377): 1011-1021. Doi: 10.1056/NEIMoa1705915</mixed-citation><mixed-citation xml:lang="en">Mas J.-L., Derumeaux G., Guillon B. et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke. New England Journal of Medicine. 2017. 11(377): 1011-1021. Doi: 10.1056/NEIMoa1705915</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Фисюк Ю.А., Харламова Н.В., Чаша Т.В. и др. Динамика концентрации простациклина в моче у глубоконедоношенных новорожденных с функционирующим артериальным протоком. Неонатология: новости, мнения, обучение. 2020. 8(1): 16-21. Doi: 10.33029/2308-2402-2020-8-1-16-21</mixed-citation><mixed-citation xml:lang="en">Fisuk Yu.A., Kharlamova N.V., Chasha T.V. et al. Dynamics of prostacycline concentration in urine of patent ductus arteriosus in preterm infants. Neonatology: News, Opinions, Training. 2020. 8(1): 16-21. Doi: 10.33029/2308-2402-2020-8-1-16-21 (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Radico F., Foglietta M., Di Fulvio M. et al. The ‘dreaded PFO’: anatomical and functional features of high risk for stroke. European Heart Journal Supplements: Journal of the European Society of Cardiology. 2021. Suppl E (23): E189-193. Doi: 10.1093/eurheartj/suab119</mixed-citation><mixed-citation xml:lang="en">Radico F., Foglietta M., Di Fulvio M. et al. The ‘dreaded PFO’: anatomical and functional features of high risk for stroke. European Heart Journal Supplements: Journal of the European Society of Cardiology. 2021. Suppl E (23): E189-193. Doi: 10.1093/eurheartj/suab119</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Gillam-Krakauer M., Mahajan K. Patent Ductus Arteriosus Treasyre Island (FL). Stat-Pearls Publishing. 2025. PMID: 28613509</mixed-citation><mixed-citation xml:lang="en">Gillam-Krakauer M., Mahajan K. Patent Ductus Arteriosus Treasyre Island (FL). Stat-Pearls Publishing. 2025. PMID: 28613509</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bancalari E. Patent Ductus Arteriosus and Short- and Long-Term Respiratory Outcomes. American Journal of Perinatology. 2016. (33): 1055-1057. Doi: 10.1055/s-0036-1586112</mixed-citation><mixed-citation xml:lang="en">Bancalari E. Patent Ductus Arteriosus and Short- and Long-Term Respiratory Outcomes. American Journal of Perinatology. 2016. (33): 1055-1057. Doi: 10.1055/s-0036-1586112</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Belopasova A.V., Chechetkin A.O., Merezhko V.D. Patent foramen ovale and migraine in ischemic stroke patients: incidence, pathogenetic interrelation and the effect of endovascular closure. Journal of Clinical Practice. 2024. 3 (15): 49-59.</mixed-citation><mixed-citation xml:lang="en">Belopasova A.V., Chechetkin A.O., Merezhko V.D. Patent foramen ovale and migraine in ischemic stroke patients: incidence, pathogenetic interrelation and the effect of endovascular closure. Journal of Clinical Practice. 2024. 3 (15): 49-59.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Дашичев В.В., Олендарь Н.В., Дашичев К.В. Гемодинамически значимый функционирующий артериальный проток у недоношенных детей: клиническая значимость и методы лечения. Вопросы практической педиатрии. 2010. 6 (5): 32-36.</mixed-citation><mixed-citation xml:lang="en">Dashichev V.V., Olendar N.V., Dashichev K.V. Hemodynamically Significant Functioning Ductus Arteriosus in Preterm Infants: Clinical Relevance and Treatment Options. Questions of practical pediatrics. 2010. 6 (5): 32-36 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Звягина Ж.А., Цой Е.Г., Игишева Л.Н. и др. Современный взгляд на функционирующий артериальный проток у недоношенных детей. Мать и дитя в Кузбассе. 2018. 4 (75): 4-12. https://cyberleninka.ru/article/n/sovremennyy-vzglyad-na-funktsioniruyuschiy-arterialnyy-protok-u-nedonoshennyh-detey</mixed-citation><mixed-citation xml:lang="en">Zvyagina Zh.A., Tsoi E.G., Igisheva L.N. et al. Modern perspective on functioning ductus arteriosus in preterm infants. Mother and baby in Kusbass. 2018. 4(75): 4-12 (In Russian). https://cyberleninka.ru/article/n/sovremennyy-vzglyad-na-funktsioniruyuschiy-arterialnyy-protok-u-nedonoshennyh-detey</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kavinsky C.J., Szerlip M., Goldsweig A.M., et al. SCAI Guidelines for the Management of Patent Foramen Ovale. Journal of the Society for Cardiovascular Angiography &amp; Interventions. 2022. 4(1): 100039. Doi: 10.1016/j.jscai.2022.100039</mixed-citation><mixed-citation xml:lang="en">Kavinsky C.J., Szerlip M., Goldsweig A.M., et al. SCAI Guidelines for the Management of Patent Foramen Ovale. Journal of the Society for Cardiovascular Angiography &amp; Interventions. 2022. 4(1): 100039. Doi: 10.1016/j.jscai.2022.100039</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации (протоколы, руководства лечения) «Открытый артериальный проток». 2024-2025-2026 (19.12.2024). Утверждены Минздравом РФ</mixed-citation><mixed-citation xml:lang="en">Clinical recommendations (protocols, treatment guidelines) "Open ductus arteriosus". 2024-2025-2026 (12/19/2024). Approved by the Ministry of Health of the Russian Federation (In Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
